{"id":"https://openalex.org/W7223867766","doi":"https://doi.org/10.1002/cpt.70533","title":"The EMA Qualification Opinion for CYP Inhibition\u2010Mediated Drug\u2013Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15","display_name":"The EMA Qualification Opinion for CYP Inhibition\u2010Mediated Drug\u2013Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15","publication_year":2026,"publication_date":"2026-10-26","ids":{"openalex":"https://openalex.org/W7223867766","doi":"https://doi.org/10.1002/cpt.70533","pmid":"https://pubmed.ncbi.nlm.nih.gov/42934176","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13710410"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.70533","doi":"https://doi.org/10.1002/cpt.70533","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70533","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70533","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70533","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057370940","display_name":"Karen Rowland Yeo","orcid":"https://orcid.org/0000-0002-7020-1970","observed_orcids":["https://orcid.org/0000-0002-7020-1970"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Karen Rowland Yeo","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0002-7020-1970","affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060323901","display_name":"Sibylle Neuhoff","orcid":"https://orcid.org/0000-0001-8809-1960","observed_orcids":["https://orcid.org/0000-0001-8809-1960"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sibylle Neuhoff","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0001-8809-1960","affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021958544","display_name":"Oliver J. D. Hatley","orcid":"https://orcid.org/0000-0003-3982-734X","observed_orcids":["https://orcid.org/0000-0003-3982-734X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Hatley","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0003-3982-734X","affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109237271","display_name":"Iain B. Gardner","orcid":"https://orcid.org/0000-0002-4811-8513","observed_orcids":["https://orcid.org/0000-0002-4811-8513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iain Gardner","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073655142","display_name":"C\u00e9line Brochot","orcid":"https://orcid.org/0000-0003-4166-8472","observed_orcids":["https://orcid.org/0000-0003-4166-8472"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9line Brochot","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0003-4166-8472","affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000680884","display_name":"Fr\u00e9d\u00e9ric Y. Bois","orcid":"https://orcid.org/0000-0002-4154-0391","observed_orcids":["https://orcid.org/0000-0002-4154-0391"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9ric Y. Bois","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0002-4154-0391","affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038126039","display_name":"Masoud Jamei","orcid":"https://orcid.org/0000-0002-3443-0194","observed_orcids":["https://orcid.org/0000-0002-3443-0194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masoud Jamei","raw_affiliation_strings":["Certara UK Limited (MID3 Division)  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0002-3443-0194","affiliations":[{"raw_affiliation_string":"Certara UK Limited (MID3 Division)  Sheffield UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5057370940"],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":{"value":4410,"currency":"USD","value_usd":4410},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.87492903,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6205999851226807,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6205999851226807,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.2985999882221222,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0348999984562397,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.8880000114440918},{"id":"https://openalex.org/keywords/competitive-inhibition","display_name":"competitive inhibition","score":0.7200000286102295},{"id":"https://openalex.org/keywords/mechanism-based-inhibition","display_name":"mechanism-based inhibition","score":0.9629999995231628},{"id":"https://openalex.org/keywords/predictive-performance","display_name":"predictive performance","score":0.6050000190734863},{"id":"https://openalex.org/keywords/model-credibility","display_name":"model credibility","score":0.5820000171661377},{"id":"https://openalex.org/keywords/context-of-use","display_name":"context of use","score":0.7820000052452087},{"id":"https://openalex.org/keywords/uncertainty-characterization","display_name":"uncertainty characterization","score":0.7839999794960022},{"id":"https://openalex.org/keywords/regulatory-decision-making","display_name":"regulatory decision-making","score":0.5389999747276306},{"id":"https://openalex.org/keywords/cyp3a4-5","display_name":"CYP3A4/5","score":0.777999997138977},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.8119999766349792},{"id":"https://openalex.org/keywords/cyp2c8","display_name":"CYP2C8","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9200000166893005},{"id":"https://openalex.org/keywords/cyp1a2","display_name":"CYP1A2","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C2780224610","wikidata":"https://www.wikidata.org/wiki/Q1530061","display_name":"Credibility","level":2,"score":0.9129999876022339},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6987000107765198},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.5943999886512756},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.4625999927520752},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4027999937534332},{"id":"https://openalex.org/C162376815","wikidata":"https://www.wikidata.org/wiki/Q2158281","display_name":"Frequentist inference","level":4,"score":0.39809998869895935},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3885999917984009},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3874000012874603},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.3598000109195709},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.33709999918937683},{"id":"https://openalex.org/C168167062","wikidata":"https://www.wikidata.org/wiki/Q1117970","display_name":"Component (thermodynamics)","level":2,"score":0.3314000070095062},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.3276999890804291},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30550000071525574},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.29899999499320984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29350000619888306},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C2780451532","wikidata":"https://www.wikidata.org/wiki/Q759676","display_name":"Task (project management)","level":2,"score":0.29089999198913574},{"id":"https://openalex.org/C12725497","wikidata":"https://www.wikidata.org/wiki/Q810247","display_name":"Baseline (sea)","level":2,"score":0.27070000767707825},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.2628999948501587}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1002/cpt.70533","doi":"https://doi.org/10.1002/cpt.70533","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70533","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70533","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13710410","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13710410/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13710410/pdf/CPT-9999-0.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"},{"id":"pmid:42934176","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42934176","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/cpt.70533","doi":"https://doi.org/10.1002/cpt.70533","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.70533","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.70533","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223867766.pdf","grobid_xml":"https://content.openalex.org/works/W7223867766.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W2146591007","https://openalex.org/W2156841554","https://openalex.org/W2533305249","https://openalex.org/W2899444542","https://openalex.org/W2901947980","https://openalex.org/W2910555254","https://openalex.org/W2981556959","https://openalex.org/W3088438577","https://openalex.org/W3098681737","https://openalex.org/W3108303196","https://openalex.org/W4323920749","https://openalex.org/W4388635281","https://openalex.org/W4404346839","https://openalex.org/W4406041730","https://openalex.org/W4415725196","https://openalex.org/W7154386164","https://openalex.org/W7157901156"],"related_works":["https://openalex.org/W4224296229","https://openalex.org/W2757228684","https://openalex.org/W3157986628","https://openalex.org/W1984755508","https://openalex.org/W4398316372","https://openalex.org/W2885852526","https://openalex.org/W2790073510","https://openalex.org/W2013257594","https://openalex.org/W2046514237","https://openalex.org/W7167336504"],"abstract_inverted_index":{"Clinical":[0],"pharmacology":[1],"and":[2,46,79,110,116,148,206,219],"pharmacometrics":[3],"teams":[4],"are":[5],"now":[6],"being":[7],"encouraged":[8],"to":[9,18,73,137,146,172,184],"implement":[10],"the":[11,40,47,68,90,129,198],"ICH":[12,162,202,234],"M15":[13,203],"framework":[14],"in":[15,22,225],"drug":[16],"development":[17],"support":[19],"model-informed":[20],"decisions":[21,228],"regulatory":[23,35,64,227],"submissions.":[24],"Although":[25],"model":[26,33,80],"performance":[27,127],"is":[28,53],"an":[29,177,194,207,233],"important":[30],"component":[31],"of":[32,43,50,94,150,156,197],"evaluation,":[34],"confidence":[36,224],"also":[37],"depends":[38],"on":[39],"intended":[41],"context":[42],"use":[44],"(CoU)":[45],"supporting":[48],"level":[49],"evidence.":[51],"This":[52],"particularly":[54],"relevant":[55],"for":[56,70,92,113,180],"physiologically":[57],"based":[58],"pharmacokinetic":[59],"(PBPK)":[60],"modeling,":[61],"where":[62],"increasing":[63],"application":[65],"has":[66],"strengthened":[67],"need":[69],"structured":[71],"approaches":[72],"evaluate":[74],"predictive":[75,126,215],"performance,":[76,216],"extrapolation,":[77],"uncertainty,":[78],"applicability.":[81],"The":[82,159],"Simcyp":[83],"Simulator":[84],"(V19R1)":[85],"was":[86],"recently":[87],"qualified":[88],"by":[89],"EMA":[91],"prediction":[93],"CYP-mediated":[95],"drug-drug":[96],"interactions":[97],"(DDIs)":[98],"involving":[99],"six":[100],"enzymes":[101],"(CYP1A2,":[102],"CYP2C8,":[103],"CYP2C9,":[104],"CYP2C19,":[105],"CYP2D6,":[106],"CYP3A4/5),":[107],"competitive":[108],"inhibition,":[109],"mechanism-based":[111],"inhibition":[112],"both":[114],"victim":[115],"perpetrator":[117],"drugs":[118],"across":[119,128],"three":[120,130],"CoUs.":[121],"Qualification":[122],"data":[123],"demonstrated":[124],"consistent":[125],"CoUs,":[131],"with":[132,193],"average":[133,140],"fold":[134,141],"errors":[135,142],"close":[136],"unity,":[138],"absolute":[139],"ranging":[143],"from":[144],"1.23":[145],"1.25,":[147],"98.8%":[149],"246":[151],"predictions":[152],"falling":[153],"within":[154,232],"2-fold":[155],"observed":[157],"values.":[158],"opinion":[160,200],"predates":[161],"M15;":[163],"however,":[164],"it":[165],"does":[166],"not":[167],"provide":[168],"either":[169],"a":[170,185],"mapping":[171,196],"its":[173],"credibility":[174,204],"concepts":[175,205],"or":[176],"operational":[178],"basis":[179],"extending":[181],"platform-level":[182],"evidence":[183],"specific":[186],"investigational":[187],"drug.":[188],"We":[189],"address":[190],"this":[191],"gap":[192],"explicit":[195],"qualification":[199,211],"onto":[201],"integrated":[208],"approach":[209],"linking":[210],"evidence,":[212],"drug-specific":[213],"validation,":[214],"uncertainty":[217],"characterization,":[218],"prospective":[220],"application,":[221],"illustrating":[222],"how":[223],"PBPK-supported":[226],"can":[229],"be":[230],"established":[231],"M15-aligned":[235],"framework.":[236]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-28T00:00:00"}